STERIS’ (TSE:STE – Free Report) – Stock analysts at Cormark lowered their FY2025 earnings per share (EPS) estimates for STERIS’ in a research note issued to investors on Monday, January 6th. Cormark analyst B. Watson now anticipates that the company will post earnings per share of $0.38 for the year, down from their prior estimate of $0.86. Cormark has a “Moderate Buy” rating on the stock.
Separately, Atb Cap Markets raised shares of STERIS’ to a “strong-buy” rating in a report on Sunday, December 22nd.
STERIS’ Stock Performance
About STERIS’
STERIS’s MISSION IS TO HELP OUR CUSTOMERS CREATE A HEALTHIER AND SAFER WORLD by providing innovative healthcare and life science product and service solutions around the globe by providing innovative healthcare and life science product and service solutions around the globe.
Further Reading
- Five stocks we like better than STERIS’
- Manufacturing Stocks Investing
- Why AMD Stock Might Already Be This Year’s Best Buy
- The How And Why of Investing in Oil Stocks
- 3 Promising Penny Stocks to Watch for Long-Term Gains in 2025
- Want to Profit on the Downtrend? Downtrends, Explained.
- The 3 Kings of Buybacks in 2024: Can They Do It Again?
Receive News & Ratings for STERIS’ Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STERIS’ and related companies with MarketBeat.com's FREE daily email newsletter.
